2000
Baxa celebrates its 25-Year Anniversary, emphasizing its focus on service and innovation, at the ASHP Mid-Year exhibit in Las Vegas, Nevada.Baxa UK expands its facilities to separate office, administration and warehousing activities.
2001
The Exacta-Mix™ 600 Universal Pump is enhanced with the release of 32-Bit Direct-Entry Software featuring user-friendly graphics and menus.Next-generation TPN-PC™ and TPN PC Plus™ Software is released, incorporating user-directed changes for enhancing safety and efficiency for TPN compounding and calculation.
CALCTPN™ Software is released, providing a calculation foundation for health management system software packages.
Baxa intoduces new logo and tagline. Technology for Solutions reinforces the company’s position as the industry leader for fluid handling technology and creating true solutions for pharmacy needs.
2002
The Exacta-Mix™ 2400 Compounder is introduced, offering state-of-the-art technology for multi-source solution compounding.2003
The Rapid-Fill™ Automated Syringe Filler is introduced, the first system designed to automate sterile batch filling in the pharmacy, which minimizes the potential for contamination and reduces pharmacy overhead.Abacus – Windows®-based order entry and calculation software for TPN compounding – introduced.
Baxa signs agreement with Carmel Pharma ab to become the exclusive US distributor of the PhaSeal® products, a closed system for safe handling of hazardous drugs.
Baxa opens new 93,000 ft2 headquarters facility in suburban Denver, with an 8,000 ft2 ISO Class V cleanroom.
Baxa UK launches a full line of enteral syringes with connecters that directly fit feeding lines. The syringes’ distinctive purple plunger fits the color coding for enteral products in Europe.
2004
Baxa UK releases the CyTwo-Fer™ Needle for vented reconstitution of hazardous drugs.Baxa expands it corporate headquarters, opening a new 15,000 ft2 building housing the sales and marketing functions.
2005
Brian Baldwin named Ernst & Young 2005 Entrepreneur of the Year.Baxa moves to direct sales in Canada, Benelux, Finland and France.
Achieves compliance to European Waste Electrical and Electronics Equipment Directive (WEEE).
Agreement signed with Samson Medical Technologies’ SmartPak™ Sterile Bulk Bags for prescription compounding.
Baxa recognized as: Colorado Bioscience Top Company of 2005; Governor's Award for Excellence in Exporting; SBA Exporter of the Year and ColoradoBiz Top Company of the Year.
eBUG (electronic Baxa Users’ Group) launched as an online community for information sharing on Baxa products, pharmacy procedures and current issues.
2006
UK operations expand to new 10,000 ft2 facility in Radius Court, Bracknell.Baxa signs distribution agreement with CDEX Inc. for the ValiMed™ Medication Validation System.
The Skills Training, Academics and Resources Center (STAR) opens for pharmacy best practice, compliance and environmental monitoring training. The unique facility features negative and positive pressure cleanrooms, classroom and demonstration areas for hands-on and didactic training experiences.
Baxa moves to direct sales in Austria
Baxa launches the first syringes for the US market designed exclusively for enteral feeding, featuring orange lettering and a distinctive stripe. Brand name NeoThrive™ designates their focus on neonatal feeding safety.
Baxa named one of the 25 best companies to work for in Colorado by the Society for Human Resource Management.
2007
Baxa and VIASYS MedSystems sign strategic co-marketing agreement for enteral syringes and specialty neonatal feeding sets.Co-marketing agreement announced with CriticalPoint for its online compliance training software.
Baxa announces direct sales in Switzerland.
TODAY
Baxa Corporation employs more than 400 associates worldwide, with annual sales of approximately $100 million.Right-sized product technology differentiates Baxa as a leader in efficiency and safety for fluid medication handling and administration applications.
Focus on the customer – through outstanding customer service and technical assistance, available 24 hours, 7 days a week – set Baxa apart from its competition.
Sales continue to achieve double-digit year-on-year growth levels. Increased international sales penetration is expected to grow the business exponentially over the next three to five years.
Pictured Above (Top to Bottom):
The Exacta-Mix™ 2400 Compounder
Current Baxa Headquarters in Englewood, Colorado
Welcoming signage in the new STAR Center facility
